Caxton Associates (New York)’s Nuvation Bio NUVB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	$117K	Sell	44,160 -26,241	-37%	-$69.8K	﹤0.01%	462
2024 Q3	$161K	Buy	70,401 +55,843	+384%	+$128K	0.01%	496
2024 Q2	$42.5K	Buy	+14,558	New	+$42.5K	﹤0.01%	463